Cocaine in Parotid Saliva, Blood and Urine - 4

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
James Cornish, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00000190
First received: September 20, 1999
Last updated: March 1, 2013
Last verified: March 2013
  Purpose

The purpose of this study is to establish the use of parotid saliva as a means of detecting and quantifying cocaine and its metabolites.


Condition Intervention Phase
Cocaine-Related Disorders
Procedure: Parotid Gland
Phase 1

Study Type: Interventional
Study Design: Primary Purpose: Diagnostic
Official Title: Cocaine in Parotid Saliva, Blood and Urine

Resource links provided by NLM:


Further study details as provided by University of Pennsylvania:

Primary Outcome Measures:
  • Cocaine & benzoylecgonine content in saliva, plasma, & urine

Estimated Enrollment: 0
Study Start Date: January 1991
Study Completion Date: February 1992
Primary Completion Date: February 1992 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000190

Locations
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178
Sponsors and Collaborators
University of Pennsylvania
Investigators
Principal Investigator: James Cornish, M.D. University of Pennsylvania
  More Information

No publications provided

Responsible Party: James Cornish, Principal Investigator, University of Pennsylvania
ClinicalTrials.gov Identifier: NCT00000190     History of Changes
Other Study ID Numbers: NIDA-00144-4, 3R01DA012268, K20-00144-4
Study First Received: September 20, 1999
Last Updated: March 1, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Substance-Related Disorders

ClinicalTrials.gov processed this record on October 23, 2014